Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled vs IV Milrinone in Mitral Valve Replacement
NCT05838846Phase 3Completed
- Sponsor
- Menoufia University
- Start
- Apr 2023
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milrinone in pulmonary hypertension (PH), sponsored by Menoufia University. Started Apr 2023; status: completed.
02
Drugs
milrinone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT05838846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838846.